Transplant biotech eGenesis snags $191M after first use of gene-edited pig kidney
Following a world-first transplant earlier this year, eGenesis has raised $191 million to continue developing genetically modified pig organs for people in dire need of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
